Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.

Epidemiological differences exist between Mycobacterium africanum (Maf)- and Mycobacterium tuberculosis (Mtb)-infected patients, but to date, contributing host factors have not been characterised. We analysed clinical outcomes, as well as soluble markers and gene expression profiles in unstimulated,...

Full description

Saved in:
Bibliographic Details
Main Authors: Leopold D Tientcheu, Mariëlle C Haks, Schadrac C Agbla, Jayne S Sutherland, Ifedayo M Adetifa, Simon Donkor, Edwin Quinten, Mohammed Daramy, Martin Antonio, Beate Kampmann, Tom H M Ottenhoff, Hazel M Dockrell, Martin O Ota
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-05-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0004701&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849472519474511872
author Leopold D Tientcheu
Mariëlle C Haks
Schadrac C Agbla
Jayne S Sutherland
Ifedayo M Adetifa
Simon Donkor
Edwin Quinten
Mohammed Daramy
Martin Antonio
Beate Kampmann
Tom H M Ottenhoff
Hazel M Dockrell
Martin O Ota
author_facet Leopold D Tientcheu
Mariëlle C Haks
Schadrac C Agbla
Jayne S Sutherland
Ifedayo M Adetifa
Simon Donkor
Edwin Quinten
Mohammed Daramy
Martin Antonio
Beate Kampmann
Tom H M Ottenhoff
Hazel M Dockrell
Martin O Ota
author_sort Leopold D Tientcheu
collection DOAJ
description Epidemiological differences exist between Mycobacterium africanum (Maf)- and Mycobacterium tuberculosis (Mtb)-infected patients, but to date, contributing host factors have not been characterised. We analysed clinical outcomes, as well as soluble markers and gene expression profiles in unstimulated, and ESAT6/CFP-10-, whole-Maf- and Mtb-stimulated blood samples of 26 Maf- and 49 Mtb-HIV-negative tuberculosis patients before, and after 2 and 6 months of anti-tuberculosis therapy. Before treatment, both groups had similar clinical parameters, but differed in few cytokines concentration and gene expression profiles. Following treatment the body mass index, skinfold thickness and chest X-ray scores showed greater improvement in the Mtb- compared to Maf-infected patients, after adjusting for age, sex and ethnicity (p = 0.02; 0.04 and 0.007, respectively). In addition, in unstimulated blood, IL-12p70, IL12A and TLR9 were significantly higher in Maf-infected patients, while IL-15, IL-8 and MIP-1α were higher in Mtb-infected patients. Overnight stimulation with ESAT-6/CFP-10 induced significantly higher levels of IFN-γ and TNF-α production, as well as gene expression of CCL4, IL1B and TLR4 in Mtb- compared to Maf-infected patients. Our study confirms differences in clinical features and immune genes expression and concentration of proteins associated with inflammatory processes between Mtb- and Maf-infected patients following anti-tuberculosis treatment These findings have public health implications for treatment regimens, and biomarkers for tuberculosis diagnosis and susceptibility.
format Article
id doaj-art-4e97c666c9cc457eb48530f44b0ac7a6
institution Kabale University
issn 1935-2727
1935-2735
language English
publishDate 2016-05-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-4e97c666c9cc457eb48530f44b0ac7a62025-08-20T03:24:30ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352016-05-01105e000470110.1371/journal.pntd.0004701Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.Leopold D TientcheuMariëlle C HaksSchadrac C AgblaJayne S SutherlandIfedayo M AdetifaSimon DonkorEdwin QuintenMohammed DaramyMartin AntonioBeate KampmannTom H M OttenhoffHazel M DockrellMartin O OtaEpidemiological differences exist between Mycobacterium africanum (Maf)- and Mycobacterium tuberculosis (Mtb)-infected patients, but to date, contributing host factors have not been characterised. We analysed clinical outcomes, as well as soluble markers and gene expression profiles in unstimulated, and ESAT6/CFP-10-, whole-Maf- and Mtb-stimulated blood samples of 26 Maf- and 49 Mtb-HIV-negative tuberculosis patients before, and after 2 and 6 months of anti-tuberculosis therapy. Before treatment, both groups had similar clinical parameters, but differed in few cytokines concentration and gene expression profiles. Following treatment the body mass index, skinfold thickness and chest X-ray scores showed greater improvement in the Mtb- compared to Maf-infected patients, after adjusting for age, sex and ethnicity (p = 0.02; 0.04 and 0.007, respectively). In addition, in unstimulated blood, IL-12p70, IL12A and TLR9 were significantly higher in Maf-infected patients, while IL-15, IL-8 and MIP-1α were higher in Mtb-infected patients. Overnight stimulation with ESAT-6/CFP-10 induced significantly higher levels of IFN-γ and TNF-α production, as well as gene expression of CCL4, IL1B and TLR4 in Mtb- compared to Maf-infected patients. Our study confirms differences in clinical features and immune genes expression and concentration of proteins associated with inflammatory processes between Mtb- and Maf-infected patients following anti-tuberculosis treatment These findings have public health implications for treatment regimens, and biomarkers for tuberculosis diagnosis and susceptibility.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0004701&type=printable
spellingShingle Leopold D Tientcheu
Mariëlle C Haks
Schadrac C Agbla
Jayne S Sutherland
Ifedayo M Adetifa
Simon Donkor
Edwin Quinten
Mohammed Daramy
Martin Antonio
Beate Kampmann
Tom H M Ottenhoff
Hazel M Dockrell
Martin O Ota
Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
PLoS Neglected Tropical Diseases
title Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
title_full Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
title_fullStr Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
title_full_unstemmed Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
title_short Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
title_sort host immune responses differ between m africanum and m tuberculosis infected patients following standard anti tuberculosis treatment
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0004701&type=printable
work_keys_str_mv AT leopolddtientcheu hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT mariellechaks hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT schadraccagbla hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT jaynessutherland hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT ifedayomadetifa hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT simondonkor hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT edwinquinten hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT mohammeddaramy hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT martinantonio hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT beatekampmann hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT tomhmottenhoff hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT hazelmdockrell hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment
AT martinoota hostimmuneresponsesdifferbetweenmafricanumandmtuberculosisinfectedpatientsfollowingstandardantituberculosistreatment